by Ahmed O. Kaseb (ed.)
Publisher: InTech 2013
Number of pages: 322
Many components of current novel therapeutic modalities for HCC are discussed in the current version of the book within the framework of a multidisciplinary approach with special emphasis on emerging treatment approaches and research strategies. This book is the essential clinical guide for oncologists, hepatologists, surgeons, and all physicians and researchers involved in the care of patients with HCC.
Home page url
Download or read it online for free here:
(multiple PDF files)
- American College of Medical Genetics
The Guidelines have been prepared to help the primary care provider to participate in the pre- and post-test education and counseling required for every patient contemplating genetic testing for breast and ovarian cancer.
by Stanley Shostak - InTech
The book goes where the cutting edge of research theory meets the challenges of clinical practice. Its text tease apart cancer's vulnerabilities and identify opportunities for early detection, targeted therapy, and reducing remission and resistance.
- International Agency for Research on Cancer
This volume provides an assessment of the carcinogenicity of 14 drugs and herbal products. The authors relied on epidemiological studies to evaluate the carcinogenic hazard to humans exposed to the drugs digoxin, pioglitazone and hydrochlorothiazide.
by S. Nass, H. Moses - National Academies Press
Many cancer patients are diagnosed at a stage in which the cancer is too far advanced to be cured. There is tremendous opportunity to improve the outcome for people with cancer by enhancing detection and treatment approaches.